How Not to Cure Chronic Diseases

Members of Congress can be astonishingly clueless about the shortcomings of federal agencies and how to correct them. At a press conference in February, United States Senator Barbara Mikulski and several bipartisan colleagues unveiled the Spending Reductions through Innovations in Therapies Act, legislation intended to spur innovation in pharmaceutical research and development for chronic and costly health conditions such as Alzheimer’s Disease, cancer, diabetes, and heart disease. But the legislation fails to address what actually impedes the development of important new medicines.

Click here to read the full publication →